Serological responses in pigs vaccinated with inactivated porcine parvovirus.
The safety and immunogenicity of inactivated porcine parvovirus (PPV) vaccines were investigated. Both beta-propiolactone and formalin successfully inactivated virus without destroying immunogenicity, which was considerably enhanced by incorporation of a gel adjuvant in the vaccine. Using the formalised-gel vaccine, initial antibody responses were demonstrated in susceptible piglets and adult pigs at 7 days after vaccination. These antibody responses persist at significant levels for at least 6 months after vaccination. Antibody levels increased up to 16 fold when revaccination was carried out. Vaccination of gilts with low level (passive) immunity resulted in antibody responses comparable to those recorded in susceptible pigs. The vaccine was safe as determined by absence of residual virus in the vaccine, absence of viraemia and excretion in vaccinted stock, and absence of effect on litters of sows vaccinated at different gestational ages. Vaccine stored at 4 degrees C for 6 months was as immunogenic as fresh vaccine.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis*; D005260:Female; D005557:Formaldehyde; D007117:Immunization, Secondary; D010321:Parvoviridae / Q000276:immunology*; D011247:Pregnancy; D011420:Propiolactone; D013552:Swine / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary*; D014765:Viral Vaccines
D000914:Antibodies, Viral; D014765:Viral Vaccines; D005557:Formaldehyde; D011420:Propiolactone